<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo270029" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39534404</article-id><article-id pub-id-type="pmc">PMC11555298</article-id>
<article-id pub-id-type="doi">10.1002/deo2.70029</article-id><article-id pub-id-type="publisher-id">DEO270029</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Combination of artificial intelligence endoscopic diagnosis and Kimura&#x02010;Takemoto classification determined by endoscopic experts may effectively evaluate the stratification of gastric atrophy in post&#x02010;eradication status</article-title><alt-title alt-title-type="left-running-head">KIRITA <sc>et al</sc>.</alt-title></title-group><contrib-group><contrib id="deo270029-cr-0001" contrib-type="author"><name><surname>Kirita</surname><given-names>Kumiko</given-names></name><xref rid="deo270029-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270029-cr-0002" contrib-type="author" corresp="yes"><name><surname>Futagami</surname><given-names>Seiji</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0502-8646</contrib-id><xref rid="deo270029-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>seiji-f@nms.ac.jp</email></address></contrib><contrib id="deo270029-cr-0003" contrib-type="author"><name><surname>Nakamura</surname><given-names>Ken</given-names></name><xref rid="deo270029-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270029-cr-0004" contrib-type="author"><name><surname>Agawa</surname><given-names>Shuhei</given-names></name><xref rid="deo270029-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270029-cr-0005" contrib-type="author"><name><surname>Ueki</surname><given-names>Nobue</given-names></name><xref rid="deo270029-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270029-cr-0006" contrib-type="author"><name><surname>Higuchi</surname><given-names>Kazutoshi</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4386-6288</contrib-id><xref rid="deo270029-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270029-cr-0007" contrib-type="author"><name><surname>Habiro</surname><given-names>Mayu</given-names></name><xref rid="deo270029-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270029-cr-0008" contrib-type="author"><name><surname>Kawawa</surname><given-names>Rie</given-names></name><xref rid="deo270029-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270029-cr-0009" contrib-type="author"><name><surname>Kato</surname><given-names>Yusuke</given-names></name><xref rid="deo270029-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo270029-cr-0010" contrib-type="author"><name><surname>Tada</surname><given-names>Tomohiro</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7221-8314</contrib-id><xref rid="deo270029-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo270029-cr-0011" contrib-type="author"><name><surname>Iwakiri</surname><given-names>Katsuhiko</given-names></name><xref rid="deo270029-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="deo270029-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology</named-content>
<institution>Nippon Medical School Hospital</institution>
<institution>Graduate School of Medicine</institution>
<city>Tokyo</city>
<country country="JP">Japan</country>
</aff><aff id="deo270029-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>AI Medical Service, Inc.</institution>
<city>Tokyo</city>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Seiji Futagami, Department of Gastroenterology, Nippon Medical School Musashikosugi Hospital, Kanagawa, Japan.<break/> Email: <email>seiji-f@nms.ac.jp</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="60">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e70029</elocation-id><history>
<date date-type="rev-recd"><day>07</day><month>10</month><year>2024</year></date>
<date date-type="received"><day>27</day><month>8</month><year>2024</year></date>
<date date-type="accepted"><day>08</day><month>10</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2024 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e70029.pdf"/><abstract><title>Abstract</title><sec id="deo270029-sec-0010"><title>Background</title><p>Since it is difficult for expert endoscopists to diagnose early gastric cancer in post&#x02010;eradication status, it may be critical to evaluate the stratification of high&#x02010;risk groups using the advance of gastric atrophy or intestinal metaplasia. We tried to determine whether the combination of endoscopic artificial intelligence (AI) diagnosis for the evaluation of gastric atrophy could be a useful tool in both pre&#x02010; and post&#x02010;eradication status.</p></sec><sec id="deo270029-sec-0020"><title>Methods</title><p>270 <italic toggle="yes">Helicobacter pylori</italic>&#x02010;positive outpatients (Study I) were enrolled and Study II was planned to compare patients (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;72) with pre&#x02010;eradication therapy with post&#x02010;eradication therapy. Assessment of endoscopic appearance was evaluated by the Kyoto classification and Kimura&#x02010;Takemoto classification. The trained neural network generated a continuous number between 0 and 1 for gastric atrophy.</p></sec><sec id="deo270029-sec-0030"><title>Results</title><p>There were significant associations between the severity of gastric atrophy determined by AI endoscopic diagnosis and not having a regular arrangement of collecting venules in angle, visibility of vascular pattern, and mucus using Kyoto classification in <italic toggle="yes">H. pylori</italic>&#x02010;positive gastritis. There were significant differences (<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.037 and <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.014) in the severity of gastric atrophy between the high&#x02010;risk group and low&#x02010;risk group based on the combination of Kimura&#x02010;Takemoto classification and endoscopic AI diagnosis in pre&#x02010; and post&#x02010;eradication status. The area under the curve values of the severity of gastric atrophy (0.674) determined by the combination of Kimura&#x02010;Takemoto classification and gastric atrophy determined by AI diagnosis was higher than that determined by Kimura&#x02010;Takemoto classification alone in post&#x02010;eradication status.</p></sec><sec id="deo270029-sec-0040"><title>Conclusion</title><p>A combination of gastric atrophy determined by AI endoscopic diagnosis and Kimura&#x02010;Takemoto classification may be a useful tool for the prediction of high&#x02010;risk groups in post&#x02010;eradication status.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo270029-kwd-0001">artificial intelligence</kwd><kwd id="deo270029-kwd-0002">atrophic gastritis</kwd><kwd id="deo270029-kwd-0003">gastric cancer</kwd><kwd id="deo270029-kwd-0004"><italic toggle="yes">Helicobacter pylori</italic></kwd><kwd id="deo270029-kwd-0005">Kyoto Classification</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>None</funding-source></award-group></funding-group><counts><fig-count count="2"/><table-count count="4"/><page-count count="8"/><word-count count="4755"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="deo270029-sec-0050"><title>INTRODUCTION</title><p>Previous studies have reported that artificial intelligence (AI) endoscopic diagnosis using deep learning in digestive tract endoscopy, especially colonoscopy.<xref rid="deo270029-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="deo270029-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="deo270029-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> Various gastrointestinal diagnoses with AI using deep learning for gastric cancer<xref rid="deo270029-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> and <italic toggle="yes">Helicobacter pylori</italic> infection status<xref rid="deo270029-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> have been reported. Expert endoscopists evaluate precancerous lesions based on endoscopic features such as intestinal metaplasia and gastric atrophy. Considering the risk factors for the development of gastric cancer, gastric atrophy, intestinal metaplasia, and enlarged&#x02010;fold appearance have been reported.<xref rid="deo270029-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="deo270029-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="deo270029-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> There were some data about the usefulness of AI endoscopic diagnosis against gastric atrophy as precancerous lesions. Considering that the number of cases after <italic toggle="yes">H. pylori</italic> eradication is currently increasing in Japan, it is critical issues to determine data about AI endoscopic diagnosis against gastric atrophy in post&#x02010;eradication status. In addition, the new Kyoto Global Consensus Meeting on <italic toggle="yes">H. pylori</italic> gastritis proposed that the risk of <italic toggle="yes">H. pylori</italic>&#x02010;infected gastritis should be determined based on the extent of gastric atrophy.<xref rid="deo270029-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> The usefulness of risk evaluation according to the Kyoto Classification of Gastritis using endoscopic features has been studied.<xref rid="deo270029-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>
</p><p>In this study, we first tried to investigate whether the severity of gastric atrophy determined by AI endoscopic diagnosis was associated with any items of modified Kyoto classification or Kimura&#x02010;Takemoto classification. Then, secondly, in a small group study, we tried to determine whether gastric atrophy determined by AI endoscopic diagnosis could be useful for the evaluation of the severity of gastric atrophy between pre&#x02010;eradication status and post&#x02010;eradication status. Since early gastric cancer found in post&#x02010;eradication status appears with indistinct forms, such as tiny and flattened lesions,<xref rid="deo270029-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="deo270029-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> it is difficult for expert endoscopists to find it. In view of the importance of the evaluation of the stratification of gastric mucosa in post&#x02010;eradication status, it may be critical issues to evaluate gastric risk including gastric atrophy via a combination of AI endoscopic diagnosis in post&#x02010;eradication status. Thus, we compared the Kimura&#x02010;Takemoto classification alone with the combination of gastric atrophy determined by AI endoscopic diagnosis and Kimura&#x02010;Takemoto classification. In this study, we first tried to determine whether endoscopic AI diagnosis for the evaluation of the severity of gastric atrophy as a precancerous lesion could be a useful tool in post&#x02010;eradication status.</p></sec><sec id="deo270029-sec-0060"><title>METHODS</title><sec id="deo270029-sec-0070"><title>Patients</title><p>This study enrolled 270 <italic toggle="yes">H. pylori</italic>&#x02010;positive outpatients, who either presented with upper gastrointestinal symptoms or received a periodical check&#x02010;up (Study I), and Study II was planned to compare the grade of gastric atrophy of patients (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;72) with pre&#x02010;eradication therapy with three years after eradication therapy in Nippon Medical School Hospital during a period spanning from 2010 to 2021 (Figure&#x000a0;<xref rid="deo270029-fig-0001" ref-type="fig">1</xref>). First, in study I, we classified 270 <italic toggle="yes">H. pylori</italic>&#x02010;positive gastritis using Kyoto classification and Kimura&#x02010;Takemoto classification, respectively. Then, the severity of gastric atrophy in 270 <italic toggle="yes">H. pylori</italic>&#x02010;positive gastritis was diagnosed using endoscopic AI. In Study I, we investigated which items of modified Kyoto classification were associated with gastric atrophy determined by endoscopic AI. We also investigated whether three items (regular arrangement of collecting venules [RAC] in angle, visibility of vascular pattern, and mucus) are actually linked to gastric atrophy determined by AI endoscopic diagnosis in <italic toggle="yes">H. pylori</italic>&#x02010;positive patients (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;270). However, there were no significant relative associations between not having RAC in angle, visibility of vascular pattern, and mucus and gastric atrophy determined by AI endoscopic diagnosis (the area under the curve [AUC]: 0.564, 0.595, and 0.566, respectively; Figure <xref rid="deo270029-supinfo-0001" ref-type="">S2</xref>). Since AI endoscopic diagnosis was not significantly associated with items of modified Kyoto classification such as not having RAC in angle, visibility of vascular pattern, and mucus in the view of AUC values (Study I), we tried to determine whether there were a significant relationship between gastric atrophy determined by AI endoscopic diagnosis and Kimura&#x02010;Takemoto classification in pre&#x02010;eradication status and post&#x02010;eradication status in Study II. In Study II, we divided 72 <italic toggle="yes">H. pylori</italic>&#x02010;positive patients into two groups, one is 16 patients with <italic toggle="yes">H. pylori</italic>&#x02010;positive patients a high&#x02010;risk group, developed into early gastric cancer in 6 years after eradication and the other is 56 <italic toggle="yes">H. pylori</italic>&#x02010;positive patients were a low&#x02010;risk group without early gastric cancer in the 6 years after eradication (Figure&#x000a0;<xref rid="deo270029-fig-0001" ref-type="fig">1</xref>). In Study II, we tried to determine whether endoscopic AI diagnosis for the evaluation of the severity of gastric atrophy could be a useful tool in pre&#x02010;eradication and post&#x02010;eradication status. Exclusion criteria included renal failure and liver cirrhosis. Patients with previous gastroduodenal surgery and recent use of non&#x02010;steroidal anti&#x02010;inflammatory drugs (NSAIDs) at endoscopy were also excluded. <italic toggle="yes">H. pylori</italic> infection was determined by the<xref rid="deo270029-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> C&#x02010;urea breath test, the positivity of <italic toggle="yes">H. pylori</italic> IgG antibody, or histological identification. Written informed consent was obtained from all subjects prior to undergoing upper gastrointestinal endoscopy. The study protocol was approved by the Ethics Review Committee of Nippon Medical School Hospital (490&#x02010;31&#x02010;19).</p><fig position="float" fig-type="FIGURE" id="deo270029-fig-0001"><label>FIGURE 1</label><caption><p>Study design.</p></caption><graphic xlink:href="DEO2-5-e70029-g001" position="anchor" id="jats-graphic-1"/></fig></sec><sec id="deo270029-sec-0080"><title>Kimura&#x02010;Takemoto classification as reference standard</title><p>We compared the severity of gastric atrophy diagnosed by expert endoscopists using the Kimura&#x02010;Takemoto classification as a reference standard.<xref rid="deo270029-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> Gastric atrophy was classified based on grades C&#x02010;0 (none), C&#x02010;I, C&#x02010;II, C&#x02010;III, O&#x02010;I, O&#x02010;II, and O&#x02010;III according to the endoscopic&#x02013;atrophic&#x02010;border scale.</p></sec><sec id="deo270029-sec-0090"><title>Assessment of endoscopic appearance based on modified Kyoto classification</title><p>Endoscopic findings described in Kyoto classification of gastritis such as the presence or absence of RAC, enlarged gastric folds, nodularity, the existence of mucus, visible vascular pattern, diffuse and/or spotty redness, or patchy redness of the gastric mucosa were scored as follows: 0, absent; and 1, present for each patient based.<xref rid="deo270029-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>
</p></sec><sec id="deo270029-sec-0100"><title>Training image sets</title><p>After selection, a total of 11,497 images, evaluated as the gold standard for the AI diagnosis, were collected for 4373 with gastric atrophy and 7124 without gastric atrophy as a training image data set determined by expert endoscopists in Osaka International Cancer Institute. The six classes are based on the presence or absence of atrophy for each region or view (antrum, body antegrade view, and body retroflex view) based on a modified previous study.<xref rid="deo270029-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>
</p></sec><sec id="deo270029-sec-0110"><title>Test image sets and evaluation algorithm</title><p>A total of 7724 images from Study I and Study II were evaluated by the CNN from Nippon Medical School Hospital. The images were taken by various endoscopes (GIF&#x02010;H290Z [51/270], GIF&#x02010;H260Z [87/270], GIF&#x02010;H260 [96/270], and GIF&#x02010;XP260N [36/270] with VISERA ELITE system [Olympus]). The definition of gastric atrophy in test image sets was determined by AI based on the training image sets.</p><p>The endoscopic images are representatively shown in Figure <xref rid="deo270029-supinfo-0001" ref-type="">S1</xref>. When expert endoscopists judged gastric atrophy in both views (Corpus&#x02010;down view and Corpus&#x02010;up view), it was classified as score 2. In addition, expert endoscopists judged no atrophy in the Corpus&#x02010;down and&#x02010;up view, and the atrophy in the cardia is classified as score 1. When expert endoscopists judged no atrophy in both views (Corpus&#x02010;down view and Corpus&#x02010;up view) and no atrophy in cardia, it was classified as score 0 (Figure <xref rid="deo270029-supinfo-0001" ref-type="">S1</xref>). The gastroenterologists as expert endoscopists for this study had at least 10 years of experience performing endoscopies.</p></sec><sec id="deo270029-sec-0120"><title>Statistical analysis</title><p>Two&#x02010;tailed unpaired <italic toggle="yes">t</italic>&#x02010;test was performed to compare continuous variables, and Pearson's chi&#x02010;square test was performed to compare categorical variables. Receiver operating characteristic (ROC) curves were created by plotting sensitivity, as a proportion, versus (1&#x02010;specificity), as a proportion. All analyses were performed using SPSS (version 27.0; IBM Corp.), and <italic toggle="yes">p</italic>&#x02010;values &#x0003c;0.05 were considered to be statistically significant.</p></sec></sec><sec id="deo270029-sec-0130"><title>RESULTS</title><sec id="deo270029-sec-0140"><title>Clinical characteristics and endoscopic features in Kyoto classification in patients with <italic toggle="yes">H. pylori</italic>&#x02010;positive gastritis</title><p>In study I, we classified 270 <italic toggle="yes">H. pylori</italic>&#x02010;positive gastritis using the Kyoto classification and Kimura&#x02010;Takemoto classification, respectively. Clinical characteristics (age 59.5&#x000b1;13.9, gender: F/M: 138/132) in study I are exhibited in Table&#x000a0;<xref rid="deo270029-tbl-0001" ref-type="table">1</xref>. In the Kimura&#x02010;Takemoto classification, in 270 <italic toggle="yes">H. pylori</italic>&#x02010;positive gastritis, the grade of gastric atrophy was the following: C&#x02010;I and C&#x02010;II: <italic toggle="yes">n</italic>&#x000a0;=&#x000a0;54 (20%), C&#x02010;III: <italic toggle="yes">n</italic>&#x000a0;=&#x000a0;19 (7%), and O&#x02010;I, O&#x02010;II, and O&#x02010;III: <italic toggle="yes">n</italic>&#x000a0;=&#x000a0;197 (73%).</p><table-wrap position="float" id="deo270029-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Characteristics of the patients in each study.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Study I (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;270)</th><th align="left" colspan="3" style="border-bottom:solid 1px #000000" rowspan="1">Study II (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;72)</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">H. pylori</italic>&#x02010;positive gastritis</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th><th align="left" rowspan="1" colspan="1">
<p>High&#x02010;risk</p>
<p>group (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;16)</p>
</th><th align="left" rowspan="1" colspan="1">
<p>Low&#x02010;risk</p>
<p>group (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;56)</p>
</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1">59.5&#x000a0;&#x000b1;&#x000a0;13.9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">69.6&#x000a0;&#x000b1;&#x000a0;12.1</td><td align="left" rowspan="1" colspan="1">63.2&#x000a0;&#x000b1;&#x000a0;11.4</td><td align="left" rowspan="1" colspan="1">0.055</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender (male/female)</td><td align="left" rowspan="1" colspan="1">132/138</td><td align="left" rowspan="1" colspan="1">0.970</td><td align="left" rowspan="1" colspan="1">15/1</td><td align="left" rowspan="1" colspan="1">30/26</td><td align="left" rowspan="1" colspan="1">0.003<sup>*</sup>
</td></tr></tbody></table><table-wrap-foot><fn id="deo270029-tbl1-note-0001"><p>Data are presented as mean&#x000a0;&#x000b1;&#x000a0;standard deviation.</p></fn><fn id="deo270029-tbl1-note-0002"><p>Two&#x02010;tailed unpaired t&#x02010;test was performed to compare age, and Pearson's chi&#x02010;square test was performed to compare gender. All analyses were performed using SPSS (version 27.0; IBM Corp.).</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Not having RAC in angle, visibility of vascular pattern and mucus were highly (92.6%, 63.3%, and 63.7%) confirmed in 270 <italic toggle="yes">H. pylori</italic>&#x02010;positive gastritis (Table&#x000a0;<xref rid="deo270029-tbl-0002" ref-type="table">2</xref>, Study I).</p><table-wrap position="float" id="deo270029-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Kyoto Classification of patients by endoscopists in Study I.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="left" span="1"/><col align="char" char="(" span="1"/><col align="left" span="1"/><col align="char" char="(" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" colspan="6" style="border-bottom:solid 1px #000000" rowspan="1">Number of patients (percentage of total patients before eradication of <italic toggle="yes">H. pylori</italic>, <italic toggle="yes">n</italic>&#x000a0;=&#x000a0;270)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Diffuse redness</td><td align="left" rowspan="1" colspan="1">62 (23.0%)</td><td align="left" rowspan="1" colspan="1">Swelling of area gastrica</td><td align="left" rowspan="1" colspan="1">97 (35.9%)</td><td align="left" rowspan="1" colspan="1">Not having RAC in the angle</td><td align="left" rowspan="1" colspan="1">250 (92.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Spotty redness</td><td align="left" rowspan="1" colspan="1">111 (41.1%)</td><td align="left" rowspan="1" colspan="1">Nodularity</td><td align="left" rowspan="1" colspan="1">25 (9.3%)</td><td align="left" rowspan="1" colspan="1">Fundic gland polyp</td><td align="left" rowspan="1" colspan="1">3 (1.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Enlarged fold</td><td align="left" rowspan="1" colspan="1">47 (17.4%)</td><td align="left" rowspan="1" colspan="1">Kammrotung</td><td align="left" rowspan="1" colspan="1">24 (8.9%)</td><td align="left" rowspan="1" colspan="1">Flat erosion</td><td align="left" rowspan="1" colspan="1">24 (8.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Atrophic fold</td><td align="left" rowspan="1" colspan="1">24 (8.9%)</td><td align="left" rowspan="1" colspan="1">Patchy redness</td><td align="left" rowspan="1" colspan="1">116 (43.0%)</td><td align="left" rowspan="1" colspan="1">Raised erosion</td><td align="left" rowspan="1" colspan="1">34 (12.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Visibility of vascular pattern</td><td align="left" rowspan="1" colspan="1">171 (63.3%)</td><td align="left" rowspan="1" colspan="1">Xanthoma</td><td align="left" rowspan="1" colspan="1">45 (16.7%)</td><td align="left" rowspan="1" colspan="1">Bleeding erosion</td><td align="left" rowspan="1" colspan="1">9 (3.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mucosal swelling</td><td align="left" rowspan="1" colspan="1">154 (57.0%)</td><td align="left" rowspan="1" colspan="1">Mucus</td><td align="left" rowspan="1" colspan="1">172 (63.7%)</td><td align="left" rowspan="1" colspan="1">Hematin</td><td align="left" rowspan="1" colspan="1">34 (12.6%)</td></tr></tbody></table><table-wrap-foot><fn id="deo270029-tbl2-note-0001"><p>Abbreviation: RAC, regular arrangement of collecting venules.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo270029-sec-0150"><title>Which items in the Kyoto classification were associated with the severity of gastric atrophy by endoscopic AI</title><p>Since endoscopic AI highly diagnosed <italic toggle="yes">H. pylori</italic>&#x02010;positive gastritis patients (174/270: 64.4 %) as score 2, we investigated which items of modified Kyoto classification were associated with gastric atrophy determined by endoscopic AI. Although not having RAC in angle, visibility of vascular pattern, and mucus were higher in patients diagnosed with severe atrophy by AI (97.1%, 70.1%, and 68.4%) and significantly associated with AI scores (<italic toggle="yes">p &#x0003c;</italic> 0.001, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.002, and <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.031; Table&#x000a0;<xref rid="deo270029-tbl-0003" ref-type="table">3</xref>, Study I) in <italic toggle="yes">H. pylori</italic>&#x02010;positive gastritis, there were some discrepancies of frequencies among not having RAC in angle, visibility of vascular pattern, and mucus in patients diagnosed with severe atrophy by AI. As not having RAC in angle, visibility of vascular pattern, and mucus will seem to be associated with gastric atrophy determined by AI endoscopic diagnosis in severe gastric atrophy in <italic toggle="yes">H. pylori</italic>&#x02010;positive gastritis, we also investigated whether three items are actually linked to gastric atrophy determined by AI endoscopic diagnosis in <italic toggle="yes">H. pylori</italic>&#x02010;positive patients (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;270) in Figure <xref rid="deo270029-supinfo-0001" ref-type="">S2</xref>. However, there were no significant relative associations between not having RAC in angle, visibility of vascular pattern, and mucus and gastric atrophy determined by AI endoscopic diagnosis (AUC: 0.564, 0.595, and 0.566, respectively) in Figure <xref rid="deo270029-supinfo-0001" ref-type="">S2</xref>.</p><table-wrap position="float" id="deo270029-tbl-0003" content-type="TABLE"><label>TABLE 3</label><caption><p>Kyoto Classification of patients diagnosed with severe atrophy by artificial intelligence (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;174) in Study I.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" colspan="6" style="border-bottom:solid 1px #000000" rowspan="1">Number of patients (percentage of total patients before eradication of <italic toggle="yes">H. pylori</italic>, <italic toggle="yes">n</italic>&#x000a0;=&#x000a0;174)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Diffuse redness</td><td align="left" rowspan="1" colspan="1">44 (25.3%)</td><td align="left" rowspan="1" colspan="1">Swelling of area gastrica</td><td align="left" rowspan="1" colspan="1">68 (39.1%)</td><td align="left" rowspan="1" colspan="1">Not having RAC in the angle</td><td align="left" rowspan="1" colspan="1">169 (97.1%)<xref rid="deo270029-tbl3-note-0001" ref-type="table-fn">
<sup>*</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Spotty redness</td><td align="left" rowspan="1" colspan="1">77 (41.3%)</td><td align="left" rowspan="1" colspan="1">Nodularity</td><td align="left" rowspan="1" colspan="1">15 (8.6%)</td><td align="left" rowspan="1" colspan="1">Fundic gland polyp</td><td align="left" rowspan="1" colspan="1">2 (1.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Enlarged fold</td><td align="left" rowspan="1" colspan="1">35 (20.1%)</td><td align="left" rowspan="1" colspan="1">Kammrotung</td><td align="left" rowspan="1" colspan="1">12 (6.9%)</td><td align="left" rowspan="1" colspan="1">Flat erosion</td><td align="left" rowspan="1" colspan="1">11 (6.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Atrophic fold</td><td align="left" rowspan="1" colspan="1">20 (11.5%)</td><td align="left" rowspan="1" colspan="1">Patchy redness</td><td align="left" rowspan="1" colspan="1">78 (44.8%)</td><td align="left" rowspan="1" colspan="1">Raised erosion</td><td align="left" rowspan="1" colspan="1">22 (12.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Visibility of vascular pattern</td><td align="left" rowspan="1" colspan="1">122 (70.1%)<xref rid="deo270029-tbl3-note-0001" ref-type="table-fn">
<sup>*</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">Xanthoma</td><td align="left" rowspan="1" colspan="1">33 (19.0%)</td><td align="left" rowspan="1" colspan="1">Bleeding erosion</td><td align="left" rowspan="1" colspan="1">4 (2.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mucosal swelling</td><td align="left" rowspan="1" colspan="1">98 (56.3%)</td><td align="left" rowspan="1" colspan="1">Mucus</td><td align="left" rowspan="1" colspan="1">119 (68.4%)<xref rid="deo270029-tbl3-note-0001" ref-type="table-fn">
<sup>*</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">Hematin</td><td align="left" rowspan="1" colspan="1">16 (9.2%)</td></tr></tbody></table><table-wrap-foot><fn id="deo270029-tbl3-note-0002"><p>Abbreviations: AI, artificial intelligence; RAC, regular arrangement of collecting venules.</p></fn><fn id="deo270029-tbl3-note-0003"><p>Pearson's chi&#x02010;square test was performed to test whether each item was significantly related to the AI score.</p></fn><fn id="deo270029-tbl3-note-0004"><p>All analyses were performed using SPSS (version 27.0; IBM Corp.).</p></fn><fn id="deo270029-tbl3-note-0001"><label>*</label><p>Items in which the percentage of patients was greater than 50% and the AI score was significantly related.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo270029-sec-0160"><title>Comparison of Kimura&#x02010;Takemoto classification with the severity of gastric atrophy determined by endoscopic AI between high&#x02010;risk group and low&#x02010;risk group</title><p>We compared the severity of gastric atrophy between the high&#x02010;risk group and the low&#x02010;risk group. In the pre&#x02010;eradication status, there were significant differences (<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.009) in the severity of gastric atrophy between the high&#x02010;risk group and low&#x02010;risk group using the Kimura&#x02010;Takemoto classification (Table&#x000a0;<xref rid="deo270029-tbl-0004" ref-type="table">4</xref>, Study II). In contrast, in the post&#x02010;eradication status, there were no significant differences (<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.082) in the severity of gastric atrophy between the high&#x02010;risk group and the low&#x02010;risk group using the Kimura&#x02010;Takemoto classification (Table&#x000a0;<xref rid="deo270029-tbl-0004" ref-type="table">4</xref>, Study II).</p><table-wrap position="float" id="deo270029-tbl-0004" content-type="TABLE"><label>TABLE 4</label><caption><p>Comparison of Kimura&#x02010;Takemoto Classification and the degree of gastric atrophy determined by artificial intelligence in Study II.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">High&#x02010;risk group</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Low&#x02010;risk group</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Pre&#x02010;eradication</th><th align="left" rowspan="1" colspan="1">Post&#x02010;eradication</th><th align="left" rowspan="1" colspan="1">Pre&#x02010;eradication</th><th align="left" rowspan="1" colspan="1">Post&#x02010;eradication</th><th align="left" rowspan="1" colspan="1">Pre&#x02010;eradication</th><th align="left" rowspan="1" colspan="1">Post&#x02010;eradication</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Kimura&#x02010;Takemoto Classification (C&#x02010;I, C&#x02010;II /C&#x02010;III/O&#x02010;I, O&#x02010;II, and O&#x02010;III)</td><td align="left" rowspan="1" colspan="1">1/0/15</td><td align="left" rowspan="1" colspan="1">1/2/13</td><td align="left" rowspan="1" colspan="1">14/13/29</td><td align="left" rowspan="1" colspan="1">12/16/28</td><td align="left" rowspan="1" colspan="1">0.009<xref rid="deo270029-tbl4-note-0006" ref-type="table-fn">
<sup>*</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">0.082</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardia<xref rid="deo270029-tbl4-note-0001" ref-type="table-fn">
<sup>&#x02020;1</sup>
</xref> (0/1)</td><td align="left" rowspan="1" colspan="1">7/9</td><td align="left" rowspan="1" colspan="1">3/13</td><td align="left" rowspan="1" colspan="1">28/28</td><td align="left" rowspan="1" colspan="1">26/30</td><td align="left" rowspan="1" colspan="1">0.659</td><td align="left" rowspan="1" colspan="1">0.047<xref rid="deo270029-tbl4-note-0006" ref-type="table-fn">
<sup>*</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Antrum<xref rid="deo270029-tbl4-note-0001" ref-type="table-fn">
<sup>&#x02020;1</sup>
</xref> (0/1)</td><td align="left" rowspan="1" colspan="1">5/11</td><td align="left" rowspan="1" colspan="1">1/15</td><td align="left" rowspan="1" colspan="1">17/39</td><td align="left" rowspan="1" colspan="1">11/45</td><td align="left" rowspan="1" colspan="1">0.945</td><td align="left" rowspan="1" colspan="1">0.205</td></tr><tr><td align="left" rowspan="1" colspan="1">Corpus&#x02010;up<xref rid="deo270029-tbl4-note-0001" ref-type="table-fn">
<sup>&#x02020;1</sup>
</xref> (0/1)</td><td align="left" rowspan="1" colspan="1">9/7</td><td align="left" rowspan="1" colspan="1">2/14</td><td align="left" rowspan="1" colspan="1">25/31</td><td align="left" rowspan="1" colspan="1">13/43</td><td align="left" rowspan="1" colspan="1">0.412</td><td align="left" rowspan="1" colspan="1">0.352</td></tr><tr><td align="left" rowspan="1" colspan="1">Corpus&#x02010;down<xref rid="deo270029-tbl4-note-0001" ref-type="table-fn">
<sup>&#x02020;1</sup>
</xref> (0/1)</td><td align="left" rowspan="1" colspan="1">7/9</td><td align="left" rowspan="1" colspan="1">0/16</td><td align="left" rowspan="1" colspan="1">22/34</td><td align="left" rowspan="1" colspan="1">16/40</td><td align="left" rowspan="1" colspan="1">0.748</td><td align="left" rowspan="1" colspan="1">0.015<xref rid="deo270029-tbl4-note-0006" ref-type="table-fn">
<sup>*</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">AI score (0/1/2)</td><td align="left" rowspan="1" colspan="1">5/0/11</td><td align="left" rowspan="1" colspan="1">0/0/16</td><td align="left" rowspan="1" colspan="1">16/0/40</td><td align="left" rowspan="1" colspan="1">8/1/47</td><td align="left" rowspan="1" colspan="1">0.835</td><td align="left" rowspan="1" colspan="1">0.230</td></tr><tr><td align="left" rowspan="1" colspan="1">Combination of Kimura&#x02010;Takemoto Classification and AI score <xref rid="deo270029-tbl4-note-0002" ref-type="table-fn">
<sup>&#x02020;2</sup>
</xref> (0/1)</td><td align="left" rowspan="1" colspan="1">5/11</td><td align="left" rowspan="1" colspan="1">3/13</td><td align="left" rowspan="1" colspan="1">34/22</td><td align="left" rowspan="1" colspan="1">30/26</td><td align="left" rowspan="1" colspan="1">0.037<xref rid="deo270029-tbl4-note-0006" ref-type="table-fn">
<sup>*</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">0.014<xref rid="deo270029-tbl4-note-0006" ref-type="table-fn">
<sup>*</sup>
</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="deo270029-tbl4-note-0003"><p>Abbreviations: AI, artificial intelligence, Pre&#x02010;eradication: before the eradication of <italic toggle="yes">H. pylori</italic>, Post&#x02010;eradication: after the eradication of <italic toggle="yes">H. pylori</italic>.</p></fn><fn id="deo270029-tbl4-note-0004"><p>Pearson's chi&#x02010;square test was performed to compare the groups.</p></fn><fn id="deo270029-tbl4-note-0005"><p>All analyses were performed using SPSS (version 27.0; IBM Corp.).</p></fn><fn id="deo270029-tbl4-note-0006"><label>
<sup>*</sup>
</label><p>In the pre&#x02010;eradication group, there were significant differences in the severity of gastric atrophy between the high&#x02010;and low&#x02010;risk group using Kimura&#x02010;Takemoto classification(<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.009). In the post&#x02010;edradication group, there were significant differences in the severity of gastric atrophy between the high&#x02010;and low&#x02010;risk group using endoscopic AI diagnosis in cardia and corpus&#x02010;down (<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.047 and <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.015). In addition, in both pre&#x02010; and post&#x02010;eradication groups, there were significant differences in the severity of gastric atrophy between the high&#x02010;risk group and low&#x02010;risk group using combination of Kimura&#x02010;Takemoto classification and endoscopic AI diagnosis (<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.037 and <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.014).</p></fn><fn id="deo270029-tbl4-note-0001"><label>
<sup>&#x02020;1</sup>
</label><p>: 1; Kimura&#x02010;Takemoto Classification is O&#x02010;I, O&#x02010;II, O&#x02010;III, and the AI score of each part is moderate or high, 0; otherwise.</p></fn><fn id="deo270029-tbl4-note-0002"><label>
<sup>&#x02020;2</sup>
</label><p>: 1; Kimura&#x02010;Takemoto Classification is O&#x02010;I, O&#x02010;II, O&#x02010;III and AI score is 2, 0; otherwise.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Then, in the pre&#x02010;eradication status, there were no significant differences (<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.659, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.945, and <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.412, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.748) in the severity of gastric atrophy between the high&#x02010;risk group and low&#x02010;risk group using endoscopic AI diagnosis in the cardia, antrum, corpus&#x02010;up, and corpus&#x02010;down. Then, in the post&#x02010;eradication status, there were no significant differences (p&#x000a0;=&#x000a0;0.205 and <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.352) in the severity of gastric atrophy between the high&#x02010;risk group and low&#x02010;risk group using endoscopic AI diagnosis in cardia and antrum. Interestingly, in the post&#x02010;eradication, there were significant differences (<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.047 and <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.015) in the severity of gastric atrophy between the high&#x02010;risk group and low&#x02010;risk group using endoscopic AI diagnosis in cardia and corpus&#x02010;down (Table&#x000a0;<xref rid="deo270029-tbl-0004" ref-type="table">4</xref>, Study II). Therefore, in both pre&#x02010;and post&#x02010;eradication, there were significant differences (<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.037 and <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.014) in the severity of gastric atrophy between the high&#x02010;risk group and low&#x02010;risk group using a combination of Kimura&#x02010;Takemoto classification and endoscopic AI diagnosis (Table&#x000a0;<xref rid="deo270029-tbl-0004" ref-type="table">4</xref>, Study II). In addition, since the ratio of open&#x02010;type atrophy (13/16) in the high&#x02010;risk group in post&#x02010;eradication status was significantly higher than that (28/56) in the low&#x02010;risk group, Kimura&#x02010;Takemoto classification alone using open&#x02010;type and closed&#x02010;type also was useful for the detection of the high&#x02010;risk group (Table&#x000a0;<xref rid="deo270029-tbl-0004" ref-type="table">4</xref>).</p></sec><sec id="deo270029-sec-0170"><title>Comparison of AUC values of the severity of gastric atrophy determined by AI endoscopic diagnosis with by combination of AI and Kimura&#x02010;Takemoto classification</title><p>To compare AUC values in the differences between the severity of gastric atrophy determined by the Kimura&#x02010;Takemoto classification alone and the severity of gastric atrophy determined by a combination of Kimura&#x02010;Takemoto classification and gastric atrophy determined by AI endoscopic diagnosis in the pre&#x02010;eradication status, we plotted ROC between two groups. The AUC value determined by the Kimura&#x02010;Takemoto classification was 0.703 and the AUC value determined by a combination of Kimura&#x02010;Takemoto classification and gastric atrophy determined by AI endoscopic diagnosis was 0.647 in the pre&#x02010;eradication status, respectively (Figure&#x000a0;<xref rid="deo270029-fig-0002" ref-type="fig">2A</xref>, Study II). In contrast, the AUC value determined by the Kimura&#x02010;Takemoto classification was 0.661 and the AUC value determined by a combination of Kimura&#x02010;Takemoto classification and gastric atrophy determined by AI endoscopic diagnosis was 0.674 in the post&#x02010;eradication status, respectively (Figure&#x000a0;<xref rid="deo270029-fig-0002" ref-type="fig">2B</xref>, Study II). Thus, the AUC value determined by a combination of Kimura&#x02010;Takemoto classification and gastric atrophy determined by AI endoscopic diagnosis was higher compared to the AUC value determined by Kimura&#x02010;Takemoto classification alone in post&#x02010;eradication status (Figure&#x000a0;<xref rid="deo270029-fig-0002" ref-type="fig">2B</xref>, Study II). The AUC value for gastric atrophy determined by AI endoscopic diagnosis alone in pre&#x02010;eradication was 0.487 and the AUC value for gastric atrophy determined by AI endoscopic diagnosis alone in post&#x02010;eradication status was 0.580 (data not shown).</p><fig position="float" fig-type="FIGURE" id="deo270029-fig-0002"><label>FIGURE 2</label><caption><p>(a) Comparison of area under the curve (AUC) values in pre&#x02010;eradication status in Study II. Receiver operating characteristic (ROC) curves. The AUC values were 0.703 for Kimura&#x02010;Takemoto Classification &#x02014;&#x02014;, 0.647 for combination of Kimura&#x02010;Takemoto Classification and Artificial Intelligence (AI) score &#x02014;&#x02014;, Reference line &#x02014;&#x02014;. ROC curves were created by plotting sensitivity, as a proportion, versus (1&#x02010;specificity), as a proportion, using SPSS. The sensitivity/specificity of AUC data was following as the Kimura&#x02010;Takemoto classification alone in pre&#x02010;eradication status (0.938/0.482) and the combination of Kimura&#x02010;Takemoto classification and gastric atrophy determined by AI endoscopic diagnosis (0.688/0.607) in pre&#x02010;eradication status. (b) Comparison of area under the curve (AUC) values in post&#x02010;eradication status in Study II. Receiver operating characteristic (ROC) curves. The AUC values were 0.661 for Kimura&#x02010;Takemoto Classification &#x02014;&#x02014;, 0.674 for combination of Kimura&#x02010;Takemoto Classification and Artificial Intelligence (AI) score &#x02014;&#x02014;, Reference line &#x02014;&#x02014;. ROC curves were created by plotting sensitivity, as a proportion, versus (1&#x02010;specificity), as a proportion, using SPSS. The sensitivity/specificity of AUC data was following as the Kimura&#x02010;Takemoto classification alone in post&#x02010;eradication status (0.813/0.500), and the combination of Kimura&#x02010;Takemoto classification and gastric atrophy determined by AI endoscopic diagnosis in post&#x02010;eradication status (0.813/0.536).</p></caption><graphic xlink:href="DEO2-5-e70029-g002" position="anchor" id="jats-graphic-3"/></fig></sec></sec><sec id="deo270029-sec-0180"><title>DISCUSSION</title><p>The major findings of this study are: (1) in <italic toggle="yes">H. pylori</italic>&#x02010;positive gastritis, there were significant associations between the severity of gastric atrophy determined by AI endoscopic diagnosis and not having RAC in angle, visibility of vascular pattern, and mucus using modified Kyoto classification; (2) both pre&#x02010; and post&#x02010;eradication status, there were significant differences in the severity of gastric atrophy between the high&#x02010;risk group and the low&#x02010;risk group based on the combination of Kimura&#x02010;Takemoto classification and endoscopic AI diagnosis; and (3) the AUC values were 0.661 determined by Kimura&#x02010;Takemoto classification, and 0.674 determined by the combination of Kimura&#x02010;Takemoto classification and gastric atrophy determined by AI endoscopic diagnosis in the post&#x02010;eradication status.</p><p>Although previous studies have reported that the AI endoscopic diagnosis system was a useful tool to detect high&#x02010;risk gastric mucosa or <italic toggle="yes">H. pylori</italic>&#x02010;positive gastric mucosa in pre&#x02010;eradication status,<xref rid="deo270029-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="deo270029-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>, <xref rid="deo270029-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> in the post&#x02010;eradication status, the combination of gastric atrophy determined by AI endoscopic diagnosis and Kimura&#x02010;Takemoto classification was more useful compared to Kimura&#x02010;Takemoto classification alone. Thus, the Kimura&#x02010;Takemoto classification alone also was useful for the detection of high&#x02010;risk groups in pre&#x02010;eradication status as described in Table&#x000a0;<xref rid="deo270029-tbl-0004" ref-type="table">4</xref>. Since the severity of atrophic gastritis is well established as an indicator of increased risk for developing gastric cancer,<xref rid="deo270029-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="deo270029-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="deo270029-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="deo270029-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> the evaluation of gastric atrophy determined by AI may be very important to predict the risk for advanced gastric cancer. In this study, we focused on the combination of gastric atrophy determined by AI endoscopic diagnosis and Kimura&#x02010;Takemoto classification to evaluate the severity of gastric atrophy more effectively compared to Kimura&#x02010;Takemoto classification alone in post&#x02010;eradication status.</p><p>Tao et al have also reported that the accuracy of the endoscopic AI system for mild gastric atrophy was higher than that for severe gastric atrophy.<xref rid="deo270029-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Since the number of cases after <italic toggle="yes">H. pylori</italic> eradication is currently increasing in Japan, further studies will be needed to clarify why the combination of gastric atrophy determined by AI endoscopic diagnosis and Kimura&#x02010;Takemoto classification could effectively evaluate the severity of gastric atrophy in the post&#x02010;eradication therapy as described in Figure&#x000a0;<xref rid="deo270029-fig-0002" ref-type="fig">2</xref>. This tendency for gastric atrophy determined by AI endoscopic diagnosis has been reported to be a similar tendency to those in intestinal metaplasia.<xref rid="deo270029-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> In addition, it may be difficult for expert endoscopists to diagnose the fainting of the border of the gastric atrophy through the re&#x02010;epithelialization and improvement of gastric atrophy after eradication.<xref rid="deo270029-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> Thus, early gastric cancer in post&#x02010;eradication status increased and it is difficult for expert endoscopists to find it. In our data, gastric atrophy determined by AI endoscopic diagnosis in post&#x02010;eradication status may be additionally a useful tool for supporting expert endoscopists.</p><p>Although several studies have reported that gastric atrophy determined by AI endoscopic diagnosis was developed to find early gastric cancer in <italic toggle="yes">H. pylori</italic>&#x02010;positive patients as well as expert endoscopists,<xref rid="deo270029-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="deo270029-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> in post&#x02010;eradication status, even expert endoscopists were difficult to find early gastric cancer. Even after the loss or eradication of <italic toggle="yes">H. pylori</italic> colonization, DNA methylation persists to some extent.<xref rid="deo270029-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> Therefore, it may be critical issues to clarify whether gastric atrophy determined by AI endoscopic diagnosis could estimate the risk of gastric cancer in post&#x02010;eradication status. This study has several limitations. First, this was a retrospective study in two institutions. Second, we used only high&#x02010;quality endoscopic images for training images, but test images taken by various endoscopes including low&#x02010;quality endoscopes. Third, in this study, gastric atrophy determined by AI endoscopic diagnosis did not detect early gastric cancer directly. Fourth, in <italic toggle="yes">H. pylori</italic>&#x02010;positive gastritis, not having RAC in angle will be significantly associated with AI endoscopic diagnosis in severe gastric atrophy such as AI score 2. In contrast, not having RAC in angle will be relatively associated with AI endoscopic diagnosis in mild gastric atrophy such as AI score 0 in <italic toggle="yes">H. pylori</italic>&#x02010;positive gastritis. Considering the above issues, there were no significant relative associations between not having RAC in angle and gastric atrophy determined by AI endoscopic diagnosis (AUC: 0.564; Figure <xref rid="deo270029-supinfo-0001" ref-type="">S2</xref>).</p><p>In addition, further studies will be needed to investigate whether AI endoscopic diagnosis for intestinal metaplasia, enlarged fold, nodularity, and diffuse redness could be associated with high&#x02010;risk groups, respectively. Taken together, in this study we addressed that gastric atrophy determined by AI endoscopic diagnosis may be useful to estimate mild gastric atrophy compared to expert endoscopists and especially, in post&#x02010;eradication status, the combination of AI endoscopic supports system can effectively evaluate the stratification of gastric atrophy as high&#x02010;risk factor.</p></sec><sec sec-type="COI-statement" id="deo270029-sec-0200"><title>CONFLICT OF INTEREST STATEMENT</title><p>None.</p></sec><sec id="deo270029-sec-0210"><title>ETHICS STATEMENT</title><p>This study has been approved by the Research Ethics Review Committee of Nippon Medical School Hospital (Approval number: 490&#x02010;31&#x02010;19).</p></sec><sec id="deo270029-sec-0220"><title>PATIENT CONSENT STATEMENT</title><p>Obtained from all patients prior to undergoing upper gastrointestinal endoscopy</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="deo270029-supinfo-0001" position="float" content-type="local-data"/><supplementary-material id="deo270029-supitem-0001" position="float" content-type="local-data"><caption><p>Figure S1: Artificial Intelligence (AI) score and typical images. A: typical endoscopic images for AI diagnosis, a: moderate to severe, b: mild to moderate, c: none to mild. B: The degree of gastric atrophy determined by AI.</p></caption><media xlink:href="DEO2-5-e70029-s002.jpg"/></supplementary-material><supplementary-material id="deo270029-supitem-0002" position="float" content-type="local-data"><caption><p>Figure S2: Comparison of area under the curve (AUC) values in H. pylori&#x02010;positive patients in Study I. Receiver operating characteristic (ROC) curves. The AUC values were 0.595 for visibility of vascular pattern &#x02014;, 0.564 for not having regular arrangement of collecting venules (RAC) in angle &#x02014;, 0.566 for mucus &#x02014;, Reference line &#x02014;.</p></caption><media xlink:href="DEO2-5-e70029-s001.jpg"/></supplementary-material></sec></body><back><ack id="deo270029-sec-0190"><title>ACKNOWLEDGMENTS</title><p>We would like to thank the engineers of AI Medical Service Incorporation for supporting the image analysis.</p></ack><ref-list id="deo270029-bibl-0001"><title>REFERENCES</title><ref id="deo270029-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo270029-cit-0001">
<string-name>
<surname>Byrne</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Chapados</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Soudan</surname>
<given-names>F</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Real&#x02010;time differentiation of adenomatous and hyperplastic diminutive colorectal polyps during analysis of unaltered videos of standard colonoscopy using a deep learning model</article-title>. <source>Gut</source>
<year>2019</year>; <volume>68</volume>: <fpage>94</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="pmid">29066576</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo270029-cit-0002">
<string-name>
<surname>Chen</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Lai</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>HHS</given-names>
</string-name>, <string-name>
<surname>Tseng</surname>
<given-names>VS</given-names>
</string-name>. <article-title>Accurate classification of diminutive colorectal polyps using computer&#x02010;aided analysis</article-title>. <source>Gastroenterology</source>
<year>2018</year>; <volume>154</volume>: <fpage>568</fpage>&#x02013;<lpage>575</lpage>.<pub-id pub-id-type="pmid">29042219</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo270029-cit-0003">
<string-name>
<surname>Misawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kudo</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Mori</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Artificial intelligence&#x02010;assisted polyp detection for colonoscopy: Initial experience</article-title>. <source>Gastroenterology</source>
<year>2018</year>; <volume>154</volume>: <fpage>2027</fpage>&#x02013;<lpage>2029</lpage>.e3.<pub-id pub-id-type="pmid">29653147</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo270029-cit-0004">
<string-name>
<surname>Hirasawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Aoyama</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tanimoto</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Application of artificial intelligence using a convolutional neural network for detecting gastric cancer in endoscopic images</article-title>. <source>Gastric Cancer</source>
<year>2018</year>; <volume>21</volume>: <fpage>653</fpage>&#x02013;<lpage>660</lpage>.<pub-id pub-id-type="pmid">29335825</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo270029-cit-0005">
<string-name>
<surname>Shichijo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Endo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Aoyama</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Application of convolutional neural networks for evaluating <italic toggle="yes">Helicobacter pylori</italic> infection status on the basis of endoscopic images</article-title>. <source>Scand J Gastroenterol</source>
<year>2019</year>; <volume>54</volume>: <fpage>158</fpage>&#x02013;<lpage>163</lpage>.<pub-id pub-id-type="pmid">30879352</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo270029-cit-0006">
<string-name>
<surname>Rugge</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Boni</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pennelli</surname>
<given-names>G</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Gastritis OLGA&#x02010;staging and gastric cancer risk: A twelve&#x02010;year clinico&#x02010;pathological follow&#x02010;up study</article-title>. <source>Aliment Pharmacol Ther</source>
<year>2010</year>; <volume>31</volume>: <fpage>1104</fpage>&#x02013;<lpage>1111</lpage>.<pub-id pub-id-type="pmid">20180784</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo270029-cit-0007">
<string-name>
<surname>Nishibayashi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kanayama</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kiyohara</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>
<italic toggle="yes">Helicobacter pylori</italic>&#x02010;induced enlarged&#x02010;fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma</article-title>. <source>J Gastroenterol Hepatol</source>
<year>2003</year>; <volume>18</volume>: <fpage>1384</fpage>&#x02013;<lpage>1391</lpage>.<pub-id pub-id-type="pmid">14675267</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo270029-cit-0008">
<string-name>
<surname>Tsai</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Hsiao</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>HB</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>The corpus&#x02010;predominant gastritis index may serve as an early marker of <italic toggle="yes">Helicobacter pylori</italic>&#x02010;infected patients at risk of gastric cancer</article-title>. <source>Aliment Pharmacol Ther</source>
<year>2013</year>; <volume>37</volume>: <fpage>969</fpage>&#x02013;<lpage>978</lpage>.<pub-id pub-id-type="pmid">23550594</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo270029-cit-0009">
<string-name>
<surname>Sugano</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tack</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kuipers</surname>
<given-names>EJ</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>.; <collab collab-type="authors">Faculty members of Kyoto Global Consensus Conference</collab>
. <article-title>Kyoto global consensus report on <italic toggle="yes">Helicobacter pylori</italic> gastritis</article-title>. <source>Gut</source>
<year>2015</year>; <volume>64</volume>: <fpage>1353</fpage>&#x02013;<lpage>1367</lpage>.<pub-id pub-id-type="pmid">26187502</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo270029-cit-0010">
<string-name>
<surname>Sugimoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ban</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ichikawa</surname>
<given-names>H</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Efficacy of the Kyoto Classification of Gastritis in identifying patients at high risk for gastric cancer</article-title>. <source>Intern Med</source>
<year>2017</year>; <volume>56</volume>: <fpage>579</fpage>&#x02013;<lpage>586</lpage>.<pub-id pub-id-type="pmid">28321054</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="deo270029-cit-0011">
<string-name>
<surname>Saka</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yagi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nimura</surname>
<given-names>S</given-names>
</string-name>. <article-title>Endoscopic and histological features of gastric cancers after successful <italic toggle="yes">Helicobacter pylori</italic> eradication therapy</article-title>. <source>Gastric Cancer</source>
<year>2016</year>; <volume>19</volume>: <fpage>524</fpage>&#x02013;<lpage>530</lpage>.<pub-id pub-id-type="pmid">25752268</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="deo270029-cit-0012">
<string-name>
<surname>Kamada</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hata</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sugiu</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Clinical features of gastric cancer discovered after successful eradication of <italic toggle="yes">Helicobacter pylori</italic>: Results from a 9&#x02010;year prospective follow&#x02010;up study in Japan</article-title>. <source>Aliment Pharmacol Ther</source>
<year>2005</year>; <volume>21</volume>: <fpage>1121</fpage>&#x02013;<lpage>1126</lpage>.<pub-id pub-id-type="pmid">15854174</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="deo270029-cit-0013">
<string-name>
<surname>Meining</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bayerd&#x000f6;rffer</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>M&#x000fc;ller</surname>
<given-names>P</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Gastric carcinoma risk index in patients infected with <italic toggle="yes">Helicobacter pylori</italic>
</article-title>. <source>Virchows Arch</source>
<year>1998</year>; <volume>432</volume>: <fpage>311</fpage>&#x02013;<lpage>314</lpage>.<pub-id pub-id-type="pmid">9565339</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="deo270029-cit-0014">
<string-name>
<surname>Nomura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ida</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Terao</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>; <collab collab-type="authors">Research Group for Establishment of Endoscopic Diagnosis of Chronic Gastritis</collab>
<article-title>. Endoscopic diagnosis of gastric mucosal atrophy: Multicenter prospective study</article-title>. <source>Dig Endosc</source>
<year>2014</year>; <volume>26</volume>: <fpage>709</fpage>&#x02013;<lpage>719</lpage>.<pub-id pub-id-type="pmid">24698334</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="deo270029-cit-0015">
<string-name>
<surname>Shichijo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aoyama</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nakahira</surname>
<given-names>H</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Application of convolutional neural networks for stratification of the degree of endoscopic atrophy on endoscopic images</article-title>. <source>United European Gastroenterol J</source>
<year>2019</year>; <volume>7</volume>: doi: <pub-id pub-id-type="doi">10.1177/2050640619854671</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="deo270029-cit-0016">
<string-name>
<surname>Tao</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>Z</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>An artificial intelligence system for chronic atrophic gastritis diagnosis and risk stratification under white light endoscopy</article-title>. <source>Dig Liver Dis</source>
<year>2024</year>; <volume>56</volume>: <fpage>1319</fpage>&#x02013;<lpage>1326</lpage>.<pub-id pub-id-type="pmid">38246825</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="deo270029-cit-0017">
<string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>J</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>An explainable artificial intelligence system for diagnosing <italic toggle="yes">Helicobacter Pylori</italic> infection under endoscopy: A case&#x02010;control study</article-title>. <source>Therap Adv Gastroenterol</source>
<year>2023</year>; <volume>16</volume>: <elocation-id>17562848231155023</elocation-id>.</mixed-citation></ref><ref id="deo270029-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="deo270029-cit-0018">
<string-name>
<surname>Lin</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>PI</given-names>
</string-name>, <string-name>
<surname>Tseng</surname>
<given-names>CD</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Application of artificial intelligence in endoscopic image analysis for the diagnosis of a gastric cancer pathogen&#x02010;<italic toggle="yes">Helicobacter pylori</italic> infection</article-title>. <source>Sci Rep</source>
<year>2023</year>; <volume>13</volume>: <elocation-id>13380</elocation-id>.<pub-id pub-id-type="pmid">37592004</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="deo270029-cit-0019">
<string-name>
<surname>Uemura</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Okamoto</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Helicobacter pylori infection and the development of gastric cancer</article-title>. <source>N Engl J Med</source>
<year>2001</year>; <volume>345</volume>: <fpage>784</fpage>&#x02013;<lpage>789</lpage>.<pub-id pub-id-type="pmid">11556297</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="deo270029-cit-0020">
<string-name>
<surname>Naylor</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Gotoda</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Dixon</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients</article-title>. <source>Gut</source>
<year>2006</year>; <volume>55</volume>: <fpage>1545</fpage>&#x02013;<lpage>1552</lpage>.<pub-id pub-id-type="pmid">16603635</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="deo270029-cit-0021">
<string-name>
<surname>Horiuchi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hirasawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fujisaki</surname>
<given-names>J</given-names>
</string-name>. <article-title>Application of artificial intelligence for diagnosis of early gastric cancer based on magnifying endoscopy with narrow&#x02010;band imaging</article-title>. <source>Clin Endosc</source>
<year>2024</year>; <volume>57</volume>: <fpage>11</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">38178327</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="deo270029-cit-0022">
<string-name>
<surname>Ishioka</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Osawa</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hirasawa</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Performance of an artificial intelligence&#x02010;based diagnostic support tool for early gastric cancers: Retrospective study</article-title>. <source>Dig Endosc</source>
<year>2023</year>; <volume>35</volume>: <fpage>483</fpage>&#x02013;<lpage>491</lpage>.<pub-id pub-id-type="pmid">36239483</pub-id>
</mixed-citation></ref><ref id="deo270029-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="deo270029-cit-0023">
<string-name>
<surname>Yang</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Lim</surname>
<given-names>JH</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Helicobacter pylori&#x02010;induced modulation of the promoter methylation of Wnt antagonist genes in gastric carcinogenesis</article-title>. <source>Gastric Cancer</source>
<year>2018</year>; <volume>21</volume>: <fpage>237</fpage>&#x02013;<lpage>248</lpage>.<pub-id pub-id-type="pmid">28643146</pub-id>
</mixed-citation></ref></ref-list></back></article>